RNA Sequencing in Drug Discovery: Strategic Design, Evolving Technologies, and Translational Impact

Tuesday, November 11, 2025

9:30 AM - 10:30 AM CT

Location:360 Stage #4, Exhibit Hall

Sponsored By

Partner Presentation Speaker(s)

Kirthi Kumar Kutumbaka, MS, PhD (he/him/his)

Associate Director
Eurofins Clinical Trial Solutions
Lenexa, Kansas

Description: RNA sequencing (RNA-Seq) has become a cornerstone in drug discovery, enabling researchers to uncover gene expression patterns, identify novel targets, and predict therapeutic responses. This session will explore the strategic design of RNA-Seq experiments, recent technological advancements, and their impact on translational research. Attendees will gain practical insights into optimizing RNA-Seq workflows to accelerate drug development and improve precision medicine outcomes.

Learning Objectives:

Explain the role of RNA-Seq in drug discovery and its advantages over traditional genomic approaches.
Identify key considerations for designing effective RNA-Seq experiments, including sample selection and sequencing depth.
Evaluate how RNA-Seq data informs target identification, biomarker discovery, and clinical decision-making.